Bovine Torovirus: Veterinary Reference

Overview and Taxonomy of Bovine Torovirus

Bovine torovirus (BToV) represents a significant, yet historically underappreciated, viral pathogen within the order Nidovirales, one principally associated with enteric disease in cattle. For decades, the study of toroviruses was overshadowed by their better-known relatives within the Coronaviridae family, primarily owing to the perception that toroviral infections were largely asymptomatic or of limited clinical consequence. This perception, however, has been systematically challenged by a growing body of evidence documenting the global distribution of BToV, its substantial role in the etiology of neonatal calf diarrhea, and the economic losses it inflicts upon the cattle industry [1, 3]. The virus is predominantly recognized as an enteric pathogen, frequently identified in diarrheic calves, and its clinical significance is often amplified through synergistic coinfections with other viral and bacterial enteropathogens, such as bovine coronavirus (BCoV), bovine rotavirus (BRV), and enterotoxigenic Escherichia coli. The importance of BToV is underlined by its inclusion in advanced molecular diagnostic panels designed for the comprehensive surveillance of calf diarrhea, highlighting its recognized role as a key etiological agent alongside BCoV, BRV, bovine viral diarrhea virus (BVDV), bovine norovirus (BNoV), and bovine enterovirus (BEV) [2, 4]. The emergence of improved molecular tools and metagenomic sequencing has since propelled BToV into the spotlight of veterinary virology, compelling a deep reassessment of its taxonomy, molecular biology, and pathogenic potential.

Taxonomic Classification and Phylogenetic Context

The taxonomic journey of the toroviruses has been one of significant refinement, driven by advances in genomic sequencing and phylogenetic analysis. Historically classified within the family Coronaviridae due to morphological and replicative similarities, BToV and other toroviruses have been reclassified into a distinct family: the Tobaniviridae [1]. This reorganization reflects fundamental differences in genome structure, replication strategy, and evolutionary divergence from coronaviruses. The current taxonomy places BToV within the order Nidovirales, a large and diverse order characterized by positive-sense, single-stranded RNA genomes and a unique nested set of subgenomic mRNAs. Within the Tobaniviridae family, BToV is assigned to the subfamily Torovirinae and the genus Torovirus, a demarcation that distinguishes it from other nidoviruses such as the Coronaviridae, Arteriviridae, and Roniviridae. The genus Torovirus comprises four recognized species: Equine torovirus (EToV), Bovine torovirus (BToV), Porcine torovirus (PToV), and Human torovirus (HToV), with the latter being a tentative species initially identified in human stool samples [1]. The taxonomic distinction at the species level is primarily based on host species specificity and genomic sequence divergence, with BToV forming a distinct monophyletic clade within the torovirus genus.

Phylogenetic analyses of BToV isolates from diverse geographical regions, including Europe and Asia, reveal a complex genetic landscape. Studies based on the spike (S) and membrane (M) genes, which are commonly used for molecular characterization, have demonstrated the existence of distinct BToV genotypes or lineages. For instance, a large epidemiological survey of calf diarrhea-associated viruses in Guangdong Province, China, identified a BToV strain (designated as type II) that clustered phylogenetically with epidemic strains from other Chinese provinces, suggesting a degree of regional evolution and dissemination [4]. Similarly, molecular characterization of BToV from Croatian cattle revealed nucleotide and amino acid differences in the S and N genes compared to reference strains, indicating ongoing genetic drift and the potential emergence of local variants [3]. The existence of these genetic variants is of critical importance, as it may influence antigenicity, host range, and pathogenicity, and poses challenges for the development of broadly effective diagnostic assays and vaccines.

Virion Structure and Genomic Architecture

The BToV virion is a pleomorphic, enveloped particle, typically spherical to ovoid in shape, with a diameter ranging from 100 to 150 nm. A defining structural characteristic of toroviruses, from which the genus derives its name (Latin torus meaning "bump" or "swelling"), is the presence of distinctive, donut-shaped or torus-like surface projections, or peplomers, embedded within the lipid envelope. These peplomers are formed by the large spike (S) glycoprotein, which is responsible for receptor binding and membrane fusion, thus serving as a primary determinant of cell tropism and a major target for neutralizing antibodies. A second, shorter surface protein, the hemagglutinin-esterase (HE) glycoprotein, is also present in BToV. The HE protein is a unique feature shared with some coronaviruses (e.g., BCoV, human OC43) and is a crucial virulence factor. It possesses receptor-binding and esterase activities, which are thought to facilitate reversible attachment to sialic acid receptors on host cells and may aid in viral entry and release from infected cells. The membrane (M) glycoprotein is a multi-pass transmembrane protein that constitutes the core of the viral envelope and is essential for virion assembly and budding. The nucleocapsid (N) protein encases the viral RNA genome, forming a helical nucleocapsid structure within the virion interior. The genome itself is a linear, positive-sense, single-stranded RNA molecule of approximately 28–30 kb in length, one of the largest among RNA viruses. It is organized with a 5′ cap and a 3′ polyadenylated tail and encodes the canonical nidovirus replication-transcription complex (ORF1a/ORF1b), which is translated from the genomic RNA to produce the large polyproteins pp1a and pp1ab, which are subsequently cleaved into non-structural proteins (nsps) responsible for genome replication and subgenomic mRNA synthesis.

Comparative Genomics and Its Implications for Pathogenesis

The molecular biology of BToV, particularly its replication strategy and the functions of its structural and accessory proteins, provides crucial insights into its pathogenesis. One of the most significant features of the torovirus genome is the presence of the HE gene, which is generally absent from most coronavirus lineages (with notable exceptions like BCoV). The BToV HE protein is a multifunctional enzyme possessing both hemagglutinin activity (binding to N-acetyl-9-O-acetylneuraminic acid) and receptor-destroying esterase activity. This dual function is believed to be critical for viral entry into the intestinal epithelium and for subsequent viral spread within the gut. The esterase activity may also play a role in the regulation of viral pathogenesis by modulating the host's inflammatory response. Reverse genetics systems, which have only recently become available for toroviruses, are now enabling researchers to dissect the specific contributions of genes like HE to BToV-induced disease [1]. These tools are essential for understanding why some BToV strains are more virulent than others and for identifying molecular determinants of host range and species specificity, especially given the high frequency of inter- and intra-recombination among toroviruses which can unpredictably alter pathogenesis or facilitate host adaptation [1].

The global significance of BToV is further underscored by its consistent detection in cattle populations with diarrhea. In a comprehensive study of 295 diarrheic calf samples from Southern China, BToV was detected at a rate of 0.34%, often in mixed infections [4]. Notably, this represented the first report of BToV circulation in that specific province, highlighting its expanding geographic range. In a separate survey in Croatia, BToV was detected in an astonishing 43.2% of fecal samples from symptomatic cattle, a prevalence that often exceeded that of the more well-known BCoV in certain samplings [3]. This high detection rate in some settings, particularly in calves with severe enteritis, strongly suggests that BToV is not merely a benign bystander but an active contributor to diarrheal disease. In fact, Lojkić et al. (2015) concluded that BToV should be regarded as a relevant pathogen for cattle that plays a synergistic role in mixed enteric infections, a finding that echoes the sentiment of the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) regarding the importance of controlling all major enteric pathogens in livestock to minimize economic losses and ensure food security [3]. While BToV is not considered a major zoonotic pathogen under the auspices of the World Health Organization (WHO), its close genetic relationship to human torovirus and its potential for recombination with other nidoviruses warrants continued surveillance and one-health oriented investigation of its evolutionary trajectory.

Virion Structure and Genomic Organization of Bovine Torovirus

Bovine torovirus (BToV), a member of the order Nidovirales, has been taxonomically reclassified from the Coronaviridae family into the newly established family Tobaniviridae, reflecting its distinct phylogenetic position and unique structural features that differentiate it from other nidoviruses [1]. Understanding the virion architecture and genomic configuration of BToV is fundamental to elucidating its pathogenic mechanisms, host range determinants, and evolutionary potential, insights that are critical for developing effective diagnostic tools, therapeutic interventions, and control strategies, particularly given the mounting evidence that BToV is a significant contributor to enteric disease in calves worldwide [1, 3].

Virion Morphology and Structural Architecture

The BToV virion exhibits a pleomorphic, enveloped morphology with characteristic spikes that project from the lipid bilayer envelope, giving the particle its distinctive "torovirus" shape, a name derived from the Latin torus, meaning "bulge" or "cushion," which describes the virion's somewhat toroidal or donut-shaped appearance under electron microscopy [1]. The virion particles range from approximately 100 to 150 nm in diameter, making them somewhat smaller than typical coronaviruses but consistent with other members of the Tobaniviridae family. The envelope is derived from host cell membranes during the budding process, which occurs at intracellular membranes, particularly the endoplasmic reticulum-Golgi intermediate compartment, a feature that reflects the virus's reliance on the host secretory pathway for morphogenesis.

The most prominent structural features of the BToV virion are the surface projections. The spike (S) protein forms the large, club-shaped peplomers that mediate viral attachment to host cell receptors and subsequent membrane fusion [1]. In BToV, the S protein is substantially shorter than that of coronaviruses, measuring approximately 10–15 nm in length compared to the 20 nm spikes of coronaviruses, and this difference in spike morphology has historically been a key distinguishing feature between these two groups of nidoviruses. The S protein of BToV is a type I transmembrane glycoprotein that forms trimers on the virion surface and is responsible for receptor binding, which for BToV involves N-acetyl-9-O-acetylneuraminic acid as a primary receptor determinant, similar to the hemagglutinin-esterase (HE) protein recognition of sialic acid substrates.

In addition to the S protein, BToV virions possess a second type of surface projection composed of the hemagglutinin-esterase (HE) protein [1]. The HE protein, a characteristic feature shared between toroviruses and some coronaviruses (specifically group II coronaviruses such as bovine coronavirus and human coronavirus OC43), forms smaller spikes that interdigitate between the larger S protein spikes. The HE protein serves a bifunctional role: it possesses lectin activity that binds to O-acetylated sialic acids on the host cell surface, and it also functions as a receptor-destroying enzyme (a sialate-O-acetylesterase) that cleaves the O-acetyl ester from sialic acid, thereby facilitating viral release from infected cells and preventing viral aggregation [1]. This balance between receptor binding and receptor destruction is critical for efficient viral spread and tropism determination.

Beneath the envelope lies the membrane (M) protein, a triple-spanning transmembrane protein that is the most abundant structural component of the virion. The M protein provides structural integrity to the viral envelope through extensive interactions with the nucleocapsid and is essential for viral assembly and budding. The M protein of toroviruses shares the general topology of coronavirus M proteins but exhibits distinct sequence features that contribute to the unique torovirus morphology. The internal structural component of the virion is the nucleocapsid (N) protein, which complexes with the viral RNA genome to form a helical nucleocapsid structure with a characteristic "doughnut-shaped" or tubular morphology that is readily distinguishable from the helical nucleocapsid of coronaviruses [1]. The N protein is a basic, phosphorylated protein that binds viral RNA with high affinity and plays critical roles in genome packaging, replication, and modulation of host cell processes.

Genomic Organization and Replicase Gene Architecture

The BToV genome is a single-stranded, positive-sense RNA molecule of approximately 28–30 kilobases (kb) in length, making it one of the largest RNA genomes among the Nidovirales, though somewhat smaller than the 27–32 kb genomes of coronaviruses [1]. The genome is capped at the 5' end and polyadenylated at the 3' end, features that allow it to function directly as mRNA for translation of the replicase polyproteins upon entry into the host cell cytoplasm. The overall genome organization follows the canonical nidovirus architecture: 5' leader sequence, replicase gene (ORF1a and ORF1b), structural protein genes (HE, S, M, N), 3' untranslated region (UTR) with poly(A) tail, interspersed with accessory open reading frames (ORFs) that vary among different isolates [1].

The replicase gene occupies the 5' two-thirds of the genome and comprises two large overlapping open reading frames, ORF1a and ORF1b, which are translated from the genomic RNA to produce two large polyproteins, pp1a and pp1ab. The expression of ORF1b requires a -1 ribosomal frameshift that occurs at a specific "slippery" sequence located at the ORF1a/ORF1b junction, a mechanism that is highly conserved among nidoviruses [1]. The efficiency of this frameshift event, typically in the range of 15–30%, determines the ratio of pp1a to pp1ab produced and is critical for maintaining the correct stoichiometry of replicative enzymes. The polyproteins are subsequently processed by viral proteases, typically a papain-like protease(s) located in the nsp3 region (PLpro) and a main protease (Mpro, also called 3CLpro) located in nsp5, into 15–16 nonstructural proteins (nsps) that assemble into the membrane-anchored replication-transcription complex (RTC) [1].

Among the most critical nsps are nsp12, which contains the RNA-dependent RNA polymerase (RdRp) domain responsible for viral RNA synthesis; nsp13, which encodes the helicase activity essential for unwinding RNA secondary structures during replication and transcription; and nsp14, which harbors both a proofreading exoribonuclease (ExoN) activity and a guanine-N7-methyltransferase (N7-MTase) activity necessary for 5' capping of viral mRNAs [1]. The presence of the ExoN proofreading function is a hallmark of the larger nidoviruses (including toroviruses and coronaviruses) and is thought to contribute to their large genome sizes by reducing the mutation rate during replication, thereby maintaining genome integrity despite the error-prone nature of RNA-dependent RNA polymerases. This proofreading capacity has significant implications for BToV evolution, as it may limit the rate of genetic change while still allowing for the accumulation of adaptive mutations and recombination events.

Structural and Accessory Protein Genes

The 3' one-third of the BToV genome encodes the structural and accessory proteins in the order: HE, S, M, and N [1]. The HE gene, located immediately downstream of the replicase gene, encodes a protein of approximately 400 amino acids that shares significant homology with the HE proteins of coronaviruses and influenza C viruses, suggesting a common ancestral origin through horizontal gene transfer events [1]. The HE protein undergoes N-linked glycosylation and forms disulfide-linked homodimers that are incorporated into the virion envelope. The sialate-O-acetylesterase active site, located within the HE lectin domain, recognizes 9-O-acetylated sialic acids and is essential for both viral entry and release. The receptor-binding and esterase activities of HE are functionally coordinated with the S protein's receptor interactions to mediate efficient infection.

The S gene encodes a type I transmembrane glycoprotein of approximately 1,500–1,600 amino acids that forms the larger surface spikes [1, 3]. The S protein is heavily N-glycosylated and is subject to proteolytic cleavage by host cell proteases, a processing event that is essential for activation of membrane fusion activity. The S protein is organized into two functional domains: the S1 domain, which mediates receptor binding and contains the receptor-binding domain (RBD) responsible for attachment to host cell surface receptors, and the S2 domain, which contains the fusion machinery, including the fusion peptide and heptad repeat regions that drive membrane fusion. The receptor-binding specificity of the BToV S protein for N-acetyl-9-O-acetylneuraminic acid determines tissue tropism and host range [1]. Molecular characterization of the S gene from field isolates has revealed significant genetic diversity, particularly in the S1 domain, which likely reflects selective pressure from host immune responses and may contribute to antigenic variation [3].

The M gene encodes a triple-spanning membrane protein of approximately 230–250 amino acids [1, 2]. The M protein interacts extensively with other structural proteins during assembly and is a key determinant of virion morphology. The N-terminal ectodomain of M is relatively short and glycosylated, while the C-terminal endodomain interacts with the nucleocapsid. The M protein of BToV also plays important roles in modulating host cell signaling pathways and interferon responses, although these functions are less well characterized than those of coronavirus M proteins.

The N gene, located at the 3' end of the structural gene cluster, encodes the nucleocapsid protein of approximately 450–500 amino acids [1, 2]. The N protein is a basic, RNA-binding protein that forms the helical nucleocapsid through interactions with genomic RNA. In addition to its structural role, the N protein of nidoviruses is multifunctional, participating in RNA synthesis, transcription regulation, and modulation of host cell processes including the stress response and innate immune signaling. The N protein is also a major immunodominant antigen, and detection of N-specific antibodies forms the basis for serological diagnostic assays for BToV infection.

The BToV genome also contains several accessory ORFs interspersed among the structural protein genes, although the number and functional significance of these accessory proteins are less well understood than in coronaviruses [1]. These accessory genes, which vary in number and sequence among different BToV isolates and strains, are thought to encode proteins that modulate host immune responses, particularly interferon antagonism. The presence of strain-specific differences in accessory gene content may contribute to variations in virulence and pathogenicity observed among BToV field isolates.

Subgenomic RNA Transcription and the Nested Set Strategy

BToV, like all nidoviruses, employs a unique transcription strategy involving the synthesis of a nested set of subgenomic (sg) mRNAs that all share a common 5' leader sequence derived from the 5' end of the genome [1]. This process is regulated by transcription regulatory sequences (TRS) located at the 5' end of each structural and accessory gene, which mediate a discontinuous transcription mechanism that couples leader acquisition to sgRNA synthesis. During negative-strand RNA synthesis, the transcription complex pauses at each TRS and undergoes a template-switching event that joins the leader sequence to the body of each mRNA, resulting in a nested set of sgRNAs that are 3' coterminal with the genome [1]. This strategy ensures that only the 5' proximal gene in each sgRNA is translated while maintaining a gradient of sgRNA abundance that is inversely related to gene distance from the 3' end, ensuring higher levels of transcription for structural proteins that are required in large quantities during virion assembly.

The molecular details of BToV RNA synthesis, including the precise mechanism of TRS recognition and template switching, remain less well characterized than those of coronaviruses, but the fundamental principles are conserved across the Nidovirales. Recent advances in torovirus reverse genetics have opened new avenues for investigating the cis-acting RNA elements and trans-acting protein factors that regulate BToV replication and transcription, providing tools that are essential for understanding the molecular biology of these viruses [1].

Recombination and Genomic Plasticity

Recombination is a hallmark of nidovirus evolution and a major driver of genetic diversity in BToV populations [1]. Both homologous RNA recombination, which occurs between related viral genomes during co-infection of the same cell, and heterologous recombination, which can involve exchange of genetic material between different torovirus species or even between toroviruses and other nidoviruses, have been documented. The frequency of recombination in BToV is facilitated by the discontinuous transcription mechanism and the processivity of the viral replicase, which can occasionally dissociate from the template RNA and rejoin at alternative sites, generating recombinant genomes.

The significance of recombination for BToV biology cannot be overstated. The emergence of novel BToV strains with altered antigenicity, host range, or pathogenicity has been linked to recombination events, particularly in the S and HE genes, where exchange of genetic material can produce viruses with novel receptor-binding properties or altered tissue tropism [1]. Furthermore, inter-species recombination between bovine and porcine toroviruses has been reported, highlighting the potential for cross-species transmission and the emergence of viruses with pandemic potential. The WOAH has recognized the importance of monitoring torovirus genetic diversity and recombination as part of broader surveillance efforts for emerging infectious diseases of livestock, particularly given the economic impact of BToV-associated diarrhea in calves and the potential for novel virus emergence through recombination.

Molecular Pathogenesis of Bovine Torovirus

Taxonomic Context and Virion Architecture

Bovine torovirus (BToV) occupies a distinct position within the order Nidovirales, having been reclassified from the Coronaviridae family into the newly established family Tobaniviridae [1]. This reclassification reflects fundamental differences in genome organization and replication strategy that underpin BToV's unique pathogenic profile. The virion itself presents a distinctive toroidal (doughnut-shaped) morphology that gives the genus its name, a structural feature that distinguishes it from the spherical coronaviruses with which it was historically grouped. The BToV particle is enveloped and contains a single-stranded, positive-sense RNA genome of approximately 28–30 kilobases, making it one of the larger RNA viruses but notably smaller than coronaviruses [1]. This genomic architecture encodes the canonical nidovirus replication-transcription complex, yet BToV exhibits several molecular adaptations that directly influence its tissue tropism, host interactions, and ultimately, its pathogenic potential in bovine populations.

Genomic Organization and Replicase Machinery

The BToV genome follows the typical nidovirus organization with a 5′ cap, a 3′ polyadenylated tail, and a nested set of subgenomic mRNAs generated through discontinuous transcription. The replicase gene occupies the 5′ two-thirds of the genome and encodes two large polyproteins, pp1a and pp1ab, the latter expressed through a ribosomal frameshift mechanism conserved across nidoviruses [1]. Proteolytic processing of these polyproteins by virus-encoded proteases yields a sophisticated array of nonstructural proteins (nsps) that assemble into the membrane-associated replication-transcription complex. Among these, the nsp12 RNA-dependent RNA polymerase (RdRp) and the nsp13 helicase form the catalytic core, while accessory nsps mediate membrane rearrangements, immune evasion, and RNA processing. The BToV replicase incorporates an exonuclease proofreading activity (nsp14-ExoN) that confers relatively high replication fidelity, a feature shared with coronaviruses and large nidoviruses that distinguishes them from other RNA viruses [1]. This proofreading capacity has profound implications for BToV pathogenesis: it permits the maintenance of a large, complex genome while limiting the accumulation of deleterious mutations, yet it simultaneously allows for the preservation of functional genetic modules that facilitate host adaptation and persistence.

Structural Protein Function and Pathogenic Determinants

The structural protein repertoire of BToV includes the spike (S), membrane (M), nucleocapsid (N), and hemagglutinin-esterase (HE) proteins. The S protein mediates receptor binding and membrane fusion, serving as the primary determinant of cell tropism. Unlike coronaviruses, where the S protein typically requires cleavage by host proteases for activation, the BToV S protein exhibits distinct cleavage patterns that influence its fusion capacity and tissue specificity [1]. The M protein, which serves as a target for molecular diagnostics such as the multiplex quantitative PCR assays developed for BToV detection, plays a central role in virion assembly and budding [2, 4]. The N protein packages the genomic RNA into helical nucleocapsids and participates in RNA synthesis and translational regulation. Crucially, both the M and N genes have been employed as targets for molecular detection and phylogenetic characterization, revealing substantial genetic diversity among circulating BToV strains [2-4].

The HE protein represents a particularly intriguing virulence determinant. This protein possesses both hemagglutinating activity and receptor-destroying esterase activity, functions that facilitate viral entry and release from host cells. The HE protein is also a major target of the host humoral immune response, and its genetic variation may influence antigenic drift and immune evasion [1]. Molecular characterization of BToV strains from Croatia revealed distinct nucleotide and amino acid differences in the S and N genes compared to reference strains, suggesting ongoing evolutionary diversification that could modulate pathogenic potential [3]. Similarly, phylogenetic analysis of BToV strains circulating in Guangdong Province, China, classified the single detected strain as type II, with clustering alongside epidemic strains from other Chinese provinces, indicating regional circulation of genetically related variants [4].

Recombination and Evolutionary Dynamics

One of the most consequential features of BToV molecular pathogenesis is the virus's capacity for genetic recombination. Frequent inter- and intra-recombinational events occur among toroviruses, a phenomenon that can dramatically alter pathogenic properties and facilitate host adaptation [1]. Recombination can generate novel S protein variants with altered receptor specificity, hybrid replicase complexes with modified replication kinetics, or chimeric structural proteins that escape pre-existing immunity. The World Organisation for Animal Health (WOAH) has recognized the significance of such evolutionary mechanisms in emerging viral pathogens, and the potential for BToV to undergo recombination with other toroviruses or even coronaviruses remains an area of active investigation. The detection of BToV in diverse geographic regions, including Europe, Asia, and the Americas, alongside the identification of genetically distinct lineages, underscores the virus's capacity for dissemination and evolution [3, 4].

Host Cell Interactions and Tissue Tropism

BToV exhibits a pronounced tropism for the intestinal epithelium, where it infects mature enterocytes lining the villi of the small and large intestine. This tropism is dictated by the expression of specific host cell receptors recognized by the viral S protein, although the precise receptor for BToV remains incompletely characterized compared to the well-defined angiotensin-converting enzyme 2 receptor for SARS-CoV-2 or the aminopeptidase N receptor for some coronaviruses. The CD169 receptor (sialoadhesin), which is expressed on bovine macrophages and functions in pathogen recognition and phagocytosis, represents a potential target for viral interaction [6]. Studies employing phage display peptide libraries have identified specific peptide motifs (APRL***HHH) that bind bovine CD169 with high affinity, suggesting that BToV or other nidoviruses may exploit this receptor for macrophage infection or immune modulation [6]. Macrophage tropism could facilitate viral dissemination, immune evasion, and the induction of inflammatory responses that contribute to enteric pathology.

Upon infection of enterocytes, BToV induces profound cellular damage characterized by villus atrophy, crypt hyperplasia, and fusion of adjacent villi. These pathological changes disrupt the absorptive and secretory functions of the intestinal epithelium, leading to malabsorptive diarrhea, electrolyte imbalance, and dehydration. The molecular mechanisms underlying these cytopathic effects involve virus-induced inhibition of host protein synthesis, disruption of cellular membrane integrity, and activation of apoptotic cascades. The N protein may contribute to these processes through its interactions with cellular signaling pathways, including the modulation of stress granules and the inhibition of interferon responses.

Synergistic Interactions in Mixed Infections

A critical dimension of BToV pathogenesis involves its frequent occurrence in mixed infections with other enteric pathogens. Field studies from Croatia demonstrated BToV detection in 43.2% of diarrheic cattle, with bovine coronavirus (BCoV) detected in 78.8% of the same population, indicating substantial co-infection rates [3]. These findings establish BToV as a relevant pathogen that plays a synergistic role in mixed enteric infections, potentially amplifying disease severity beyond what would be expected from either pathogen alone. The molecular basis for this synergism likely involves virus-induced immunosuppression, disruption of epithelial barrier function, and enhanced replication of co-infecting agents.

In Guangdong Province, China, a comprehensive survey of calf diarrhea identified BToV in 0.34% of samples, with BEV (6.10%), BRV (10.85%), and BVDV (2.03%) circulating concurrently [2, 4]. While the BToV detection rate appeared low, the identification of this virus in a region where it had not been previously reported highlights its emerging distribution and the need for continued surveillance. Notably, BToV and BNoV were reported for the first time in Guangdong Province, indicating that these pathogens are more widely distributed than previously recognized and may be contributing to enteric disease complexes that have been attributed solely to more established pathogens [4].

Epidemiological Context and Molecular Surveillance

The global distribution of BToV in cattle populations has been documented through molecular surveillance studies employing RT-PCR and sequencing approaches. Reference-based metatranscriptomic sequencing has emerged as a powerful tool for viral detection, with studies demonstrating that sequencing depths of ≥10 million reads are sufficient for detection of BToV in samples with high cycle threshold values by qRT-PCR, while complete genome recovery requires lower Ct values (<30) [5]. These methodological insights are critical for interpreting molecular epidemiology data and for designing surveillance programs that accurately capture BToV prevalence and diversity.

The economic significance of BToV-induced diarrhea in calves has been recognized worldwide, with the virus contributing to substantial morbidity, mortality, and reduced growth performance in affected herds [1]. The molecular pathogenesis of BToV must therefore be understood not only in terms of virus–host interactions at the cellular level but also in the broader context of herd-level disease dynamics and the economic burden imposed on the cattle industry.

Implications for Diagnostics and Control

Understanding the molecular pathogenesis of BToV has direct implications for diagnostic assay design and the development of control strategies. The multiplex quantitative PCR assays that target the BToV M gene provide sensitive and specific detection, with documented limits of detection as low as 12.8 copies/μL for plasmid standards [2]. Such assays facilitate rapid identification of BToV in clinical specimens, enabling timely implementation of management interventions and supporting epidemiological investigations. The genetic diversity revealed through sequencing of the M, S, and N genes informs the selection of conserved target regions for diagnostic primers and probes, ensuring robust detection across circulating strains.

The molecular characterization of BToV strains from Croatia and China has demonstrated that field isolates exhibit significant genetic divergence from reference strains, with implications for vaccine development and the interpretation of serological surveys [3, 4]. The absence of commercially available vaccines for BToV, unlike the situation for BCoV, BRV, and BVDV, underscores the need for continued basic research into BToV molecular biology to identify candidate antigens and protective epitopes [2]. The reverse genetics systems recently developed for toroviruses represent a transformative tool for dissecting the molecular determinants of pathogenesis and for constructing attenuated vaccine candidates [1].

The recognition of BToV as a pathogen of veterinary importance has been accelerated by the application of advanced molecular tools, including next-generation sequencing, comparative genomics, and functional analyses of viral proteins. These approaches are revealing the intricate molecular mechanisms by which BToV replicates, evades host defenses, and causes disease, while also highlighting the virus's capacity for evolutionary change that could alter its pathogenic potential or host range in the future.

Epidemiology and Transmission Dynamics of Bovine Torovirus

Bovine torovirus (BToV), a member of the family Tobaniviridae within the order Nidovirales, represents an increasingly recognized enteric pathogen of cattle with a global distribution that has been historically underappreciated due to its often subclinical presentation and the challenges associated with its cultivation in vitro [1]. The epidemiological profile of BToV is characterized by its ubiquitous presence in cattle populations worldwide, a pronounced age-associated susceptibility in neonatal calves, and a transmission ecology intimately linked to the fecal-oral route within intensive livestock operations. Understanding the nuanced dynamics of BToV transmission is essential for the development of effective control strategies, particularly given the virus's demonstrated capacity for genetic recombination and its synergistic role in the etiopathogenesis of the bovine respiratory disease complex and neonatal calf diarrhea syndromes [1, 3]. The World Organisation for Animal Health (WOAH) recognizes the importance of nidoviruses in livestock health, and the evolving understanding of BToV epidemiology underscores the need for systematic surveillance analogous to that established for bovine coronavirus (BCoV) and other enteric pathogens.

Global Prevalence and Geographic Distribution

The available epidemiological evidence indicates that BToV circulates extensively across diverse geographic regions and production systems. Studies have documented the presence of BToV in European cattle populations, with a particularly illustrative investigation in Croatia revealing that BToV was detected in 43.2% of fecal samples collected from diarrheic cattle over a three-year surveillance period [3]. This finding is especially significant because the same study concurrently detected BCoV in 78.8% of samples, demonstrating that BToV is a consistently present, albeit less dominant, component of the enteric virome. The prevalence of BToV in this Croatian cohort suggests that the virus is endemic within European dairy and beef herds, circulating alongside other established enteric pathogens. The investigation further identified BToV not only in diarrheic animals but also in fecal samples from calves presenting with respiratory symptoms, hinting at a broader tissue tropism and transmission route than previously appreciated [3].

In Asia, the epidemiological picture of BToV is emerging through the application of advanced molecular diagnostics. Recent comprehensive surveys of calf diarrhea in Guangdong Province, China, have identified BToV at a prevalence of 0.34% among 295 diarrheic samples, representing the first documentation of BToV circulation in this region [2, 4]. While this prevalence appears low relative to the Croatian data, it is critical to interpret these figures within the context of the study population: these samples were drawn from diarrheic calves that were simultaneously tested for a panel of six viral pathogens, including bovine rotavirus (BRV) and bovine enterovirus (BEV), which exhibited significantly higher detection rates of 10.85% and 6.10%, respectively [2]. The comparatively lower detection rate of BToV in this single geographic survey does not diminish its epidemiological significance but rather reflects the complex, multi-factorial etiology of neonatal diarrhea and the potential for BToV to be present as a subdominant pathogen in mixed infections. Phylogenetic characterization of the single BToV isolate from Guangdong classified it as belonging to type II, demonstrating genetic kinship with epidemic strains circulating in other Chinese provinces [4]. This finding suggests a degree of genetic continuity and viral traffic across the Chinese cattle network, potentially facilitated by the movement of animals between regions.

The global distribution of BToV is further supported by serological studies, although these remain less extensive than molecular surveys. The difficulty in cultivating BToV in conventional cell lines has historically hampered the development and standardization of serological assays, leading to a reliance on molecular detection methods for epidemiological investigations [1]. Nevertheless, the consistent detection of BToV RNA in fecal samples from symptomatic and asymptomatic cattle across Europe, Asia, and the Americas, as synthesized by Ujike and Taguchi (2021), supports the conclusion that BToV is a globally distributed pathogen with a largely endemic transmission pattern [1]. The virus appears to circulate persistently within herds, with periodic outbreaks of clinical disease triggered by factors such as the introduction of naïve animals, the waning of maternally derived immunity in calves, or co-infections with other enteric or respiratory pathogens.

Age-Related Susceptibility and Transmission Within Herds

A defining epidemiological characteristic of BToV is its pronounced age-related susceptibility, with the most severe clinical manifestations observed in neonatal calves, typically within the first three weeks of life. This pattern mirrors that observed for BCoV and bovine rotavirus, reflecting the immunological naivety of the neonatal gut and the immature nature of the mucosal immune system. The fecal-oral route constitutes the primary mode of transmission, with infected calves shedding large quantities of virus in their diarrhea, thereby contamininating the immediate environment, including bedding, feeding utensils, and the perineal region of the dam [1]. The virus exhibits a tropism for the mature enterocytes lining the villi of the small and large intestines, leading to villous atrophy, malabsorption, and profuse, watery diarrhea. In the Croatian study, BToV was detected across a wide age spectrum, from young calves to adult cattle, although the majority of detections were associated with young animals exhibiting clinical signs of enteritis [3].

The role of adult cattle in the transmission dynamics of BToV is a critical, yet incompletely understood, component of its epidemiology. While clinical disease is predominantly a feature of young calves, adult cows can serve as asymptomatic carriers, intermittently shedding BToV in their feces. This subclinical shedding is of paramount importance for the maintenance of the virus within the herd and for the infection of successive cohorts of susceptible calves. The calving and maternity pen environment represents a high-risk nexus for transmission, where naïve newborn calves are exposed to a contaminated environment containing virus shed by their dams and other adult animals. The relatively high prevalence of BToV (over 40%) in the Croatian diarrheic cattle, which included adult animals, suggests that the virus circulates endemically within the adult population, providing a continuous source of infectious virus for neonatal animals [3]. The absence of robust, sterilizing immunity following natural infection likely permits repeated reinfection of adult animals, further contributing to the persistence of the virus within the herd.

Co-Infection Dynamics and Synergistic Pathogenesis

The epidemiology of BToV cannot be considered in isolation, as the virus frequently circulates as part of a complex of co-infecting enteric and respiratory pathogens. The Croatian study provides compelling evidence of the synergistic role of BToV in mixed infections: all fecal samples that were positive for BToV were also positive for BCoV [3]. This absolute co-occurrence suggests a strong epidemiological association between these two nidoviruses, which may be driven by shared transmission routes, similar environmental persistence, or potentially a biological synergy at the level of the host. Co-infection with BCoV, a recognized primary enteric pathogen, may enhance BToV replication or pathology, or vice versa, leading to more severe clinical signs than infection with either virus alone. This synergistic interaction has significant implications for disease diagnosis and management, as diagnostic panels targeting only a single pathogen may underestimate the true burden of BToV-associated disease.

Beyond BCoV, BToV is frequently detected in animals infected with a plethora of other agents, including bovine rotavirus, bovine viral diarrhea virus (BVDV), bovine norovirus, and various enteropathogenic bacteria. The concept of the "enteric virome" is crucial here: the clinical outcome of BToV infection is likely modulated by the composition of the entire microbial community within the gut. In the Guangdong Province survey, BToV was detected in a sample that was simultaneously positive for other viruses, reinforcing the concept that single-pathogen causation is the exception rather than the rule in neonatal calf diarrhea [4]. The presence of immunosuppressive pathogens, such as BVDV, could predispose calves to more severe BToV infection by impairing the mucosal immune response. Ujike and Taguchi (2021) have highlighted that coinfections with other pathogens can exacerbate the symptoms of torovirus infections, as observed in porcine torovirus [1]. This principle is directly applicable to BToV, where the disease outcome in a calf may be determined not solely by BToV infection, but by the intricate interplay of multiple concurrent infections.

Molecular Epidemiology and Zoonotic Potential

The molecular epidemiology of BToV, particularly its remarkable propensity for genetic recombination, is a dominant factor shaping its transmission dynamics and evolutionary trajectory. BToV, like other nidoviruses, possesses a large, single-stranded, positive-sense RNA genome that is prone to recombination events during replication. Ujike and Taguchi (2021) have emphasized that frequent inter- or intra-recombination among toroviruses can increase pathogenesis or enable unpredicted host adaptation [1]. This recombination potential raises the specter of the emergence of novel BToV strains with altered tissue tropism, increased virulence, or expanded host range. Phylogenetic analyses of BToV strains from different geographic regions, including Croatia and China, have revealed nucleotide and amino acid differences relative to reference strains, particularly in the spike (S) glycoprotein gene, which is a major determinant of host cell tropism and antigenicity [3, 4]. The S protein, which mediates receptor binding and membrane fusion, is a hotspot for genetic variation, and changes in this protein could facilitate adaptation to new hosts or evasion of host immune responses.

The classification of BToV into distinct genotypes, such as the Type II strain identified in China, is important for understanding its global phylogeography and for assessing the cross-protective efficacy of potential vaccines [4]. The presence of a specific BToV type in Guangdong that is genetically similar to strains from other Chinese provinces indicates that the virus is not geographically restricted but can spread across large distances, likely through the transportation of live animals. The existence of a distinct Type I clade suggests a deeper evolutionary divergence, and the clinical and epidemiological significance of these genotypes remains to be fully elucidated.

Critically, the zoonotic potential of BToV remains an open and concerning question. While bovine torovirus is primarily considered a pathogen of cattle, toroviruses have been detected in humans, and the close phylogenetic relationship between animal and human toroviruses, coupled with the recombination capabilities of the virus, raises the possibility of cross-species transmission. The WOAH and the World Health Organization (WHO) maintain a keen interest in emerging zoonotic nidoviruses, particularly in light of the pandemic potential demonstrated by coronaviruses. The frequent recombination observed in BToV could theoretically generate a strain capable of infecting human cells, a scenario that underscores the importance of robust One Health surveillance at the human-animal interface. The detection of BToV in cattle populations globally, combined with its genetic plasticity, makes it a virus of potential public health concern, warranting continued molecular surveillance and risk assessment.

Transmission Routes and Environmental Persistence

The primary transmission route for BToV is the fecal-oral pathway, driven by the shedding of high concentrations of virus in the diarrheic feces of infected calves. The virus is thought to be moderately resistant to environmental degradation, allowing it to persist in contaminated environments, such as soiled bedding, manure slurry, and contaminated water sources, for extended periods. This environmental stability facilitates both direct transmission between animals and indirect transmission via fomites, including contaminated boots, clothing, feeding equipment, and veterinary instruments. The role of the farm environment as a viral reservoir is particularly significant in intensive indoor housing systems, where high animal densities and limited space facilitate the accumulation and persistence of infectious material.

The detection of BToV in nasal swabs from calves with respiratory symptoms, as reported by Lojkić et al. (2015), introduces the possibility of an additional respiratory route of transmission [3]. While the primary site of BToV replication is the intestinal tract, the virus may also be capable of replicating in the respiratory epithelium, leading to shedding in nasal secretions. This finding has important implications for transmission dynamics, as it suggests that the virus could spread more rapidly through a herd via aerosol or droplet transmission, particularly in the crowded conditions of calf housing. Further research is needed to determine the relative contribution of fecal-oral versus respiratory transmission to the overall spread of BToV within and between herds.

Diagnostic Challenges and Implications for Epidemiological Surveillance

Accurate epidemiological characterization of BToV is fundamentally constrained by the diagnostic tools available. The conventional gold standard for enteric pathogen detection, viral culture, is notoriously difficult for BToV due to its fastidious growth requirements and the historical lack of a permissive cell line [1]. The advent of molecular diagnostics, particularly reverse transcription polymerase chain reaction (RT-PCR) and quantitative RT-PCR (RT-qPCR), has revolutionized BToV detection. The development of multiplex real-time fluorescence-based quantitative PCR assays that simultaneously detect BToV alongside other calf diarrhea viruses, as reported by Meng et al. (2024), offers a powerful tool for understanding its epidemiological role in the context of mixed infections [2]. These assays can achieve very high analytical sensitivity, with a reported limit of detection as low as 12.8 copies/μL for the BToV target [2]. However, even with these sensitive assays, the detection of BToV RNA in a sample does not distinguish between active infection and passive shedding of residual viral nucleic acid.

The application of metatranscriptomic sequencing represents a further frontier in BToV diagnostics and epidemiology. As demonstrated by Brito et al. (2026), metatranscriptomics can enable the detection of BToV (referred to as bovine nidovirus (BNV) in that study) in nasal swabs, even at high cycle threshold (Ct) values, providing a genotype-agnostic detection platform [5]. However, the study also revealed that BToV detection was sensitive to sequencing depth and reference genome choice; recovering high genome completeness was only achieved for samples with Ct values below 30 [5]. This finding is critical for surveillance programs, as it highlights the potential for false-negative results in samples with low viral loads. The choice of reference genome was particularly important for BToV detection, likely reflecting the significant genetic divergence between field strains and available RefSeq reference sequences [5]. This observation underscores the necessity of using locally relevant reference sequences for metatranscriptomic epidemiological studies to avoid underestimating BToV prevalence.

In conclusion, the epidemiology and transmission dynamics of BToV are defined by its global endemicity, its pivotal role as a co-pathogen in the neonatal calf diarrhea complex, its capacity for genetic recombination, and its predominant fecal-oral transmission route. The virus circulates persistently within adult cattle populations, providing a continuous source of infection for highly susceptible neonatal calves. While clinical disease is most severe in young animals, the subclinical shedding by adults is the engine of its endemic transmission. The synergistic interactions with BCoV and other pathogens amplify its clinical impact, while its genetic plasticity, particularly in the spike glycoprotein, confers the potential for host adaptation and the emergence of novel strains. The development and deployment of sensitive molecular diagnostics, including multiplex RT-qPCR and metatranscriptomic sequencing, are essential for elucidating the true prevalence and transmission dynamics of BToV, informing evidence-based control strategies, and evaluating its zoonotic risk within a One Health framework.

Clinical Manifestations and Pathology Associated with Bovine Torovirus

Bovine torovirus (BToV), a member of the family Tobaniviridae within the order Nidovirales, is increasingly recognized as a significant enteric pathogen of cattle, particularly neonatal calves. While historically overshadowed by bovine coronavirus (BCoV) and rotavirus, accumulating evidence from global surveillance studies has solidified BToV’s role as a primary etiological agent of neonatal calf diarrhea, often acting in synergy with other enteric pathogens to exacerbate clinical disease [1, 3]. The clinical manifestations and pathological sequelae of BToV infection are highly dependent on the age and immune status of the host, the viral strain, and the presence of concurrent infections. Understanding these facets is critical for accurate diagnosis, effective herd management, and the development of targeted intervention strategies.

Clinical Manifestations: From Subclinical Shedding to Severe Enteritis

The clinical spectrum of BToV infection ranges from asymptomatic shedding in adult cattle to severe, life-threatening diarrhea in young calves. In neonatal calves, typically between one and three weeks of age, the disease often presents acutely. The hallmark clinical sign is profuse, watery to mucoid diarrhea, which may be yellow to white in color and occasionally contain flecks of blood or mucus [1, 3]. This enteric loss is frequently accompanied by profound dehydration, metabolic acidosis, electrolyte imbalances, and marked depression. Affected calves exhibit anorexia, weakness, and a sunken-eyed appearance due to fluid loss. Fever is not a consistent feature, but mild to moderate pyrexia may be observed in the early stages of infection. In severe cases, particularly those complicated by co-infections with BCoV, bovine rotavirus (BRV), or enterotoxigenic Escherichia coli, the clinical course can rapidly progress to recumbency, hypothermia, and death within 24 to 72 hours of symptom onset [2, 4].

A critical aspect of BToV epidemiology is the role of subclinically infected adult cattle. Unlike young calves, adult cows frequently serve as asymptomatic carriers, shedding the virus in their feces without displaying overt clinical signs [1]. This subclinical shedding is a major mechanism for viral persistence within a herd and the contamination of the calving environment. Stressors such as parturition, transport, or dietary changes can trigger recrudescence of viral shedding, leading to the introduction of BToV to susceptible neonates. The virus has also been detected in nasal swabs from calves with respiratory symptoms, suggesting a potential, albeit less characterized, role in bovine respiratory disease complex, though its primary tropism remains the intestinal tract [3].

Pathological Mechanisms and Gross Pathology

The pathological basis of BToV-induced diarrhea is rooted in its selective tropism for the differentiated enterocytes lining the villi of the small and large intestines. Following oral-fecal transmission, the virus infects and replicates within the mature absorptive epithelial cells of the jejunum and ileum, and to a lesser extent, the colon. The primary pathological consequence is villous atrophy, a dramatic shortening and blunting of the intestinal villi. This loss of absorptive surface area is the direct cause of the malabsorptive diarrhea characteristic of the disease. The destruction of mature enterocytes also leads to a loss of brush-border enzymes, most notably lactase, resulting in an inability to digest and absorb lactose. The resulting osmotic gradient draws water into the intestinal lumen, compounding the fluid loss [1, 3].

Gross pathological findings at necropsy are largely confined to the gastrointestinal tract. The small intestine, particularly the distal jejunum and ileum, appears thin-walled, flaccid, and distended with watery, yellowish contents. The intestinal mucosa may be hyperemic and congested. The mesenteric lymph nodes are often enlarged and edematous, reflecting the local immune response. In severe cases, the colon may also be involved, with the cecal and colonic mucosa appearing hemorrhagic or ulcerated. The abomasum is typically distended with milk or fluid, indicative of delayed gastric emptying secondary to intestinal stasis. Dehydration is evident systemically, with sunken eyes, dry mucous membranes, and a loss of skin turgor. Other organs, such as the lungs and kidneys, may show signs of hypoperfusion or secondary bacterial infection in protracted cases.

Histopathology and Cellular Pathogenesis

Histological examination of affected intestinal segments reveals the hallmark lesion of BToV infection: severe, diffuse villous atrophy. The villi are markedly shortened, often to less than half their normal height, and may be fused or clubbed. The crypts of Lieberkühn, in contrast, are typically hyperplastic and elongated, representing a compensatory regenerative response to the loss of villous enterocytes. The lamina propria is infiltrated with a mixed population of inflammatory cells, including lymphocytes, plasma cells, and macrophages. Necrotic enterocytes are frequently observed sloughing from the tips of the remaining villi, and syncytial cell formation, a fusion of infected cells, has been reported in some cases [3].

At the ultrastructural level, BToV particles, characterized by their distinctive torus-shaped (doughnut-like) morphology, can be identified within cytoplasmic vesicles of infected enterocytes. The virus induces a cytopathic effect characterized by vacuolation of the cytoplasm, dilation of the endoplasmic reticulum, and disruption of the cellular cytoskeleton. The loss of tight junction integrity between enterocytes further contributes to the paracellular leakage of fluid and electrolytes into the intestinal lumen. The pathogenesis is not merely a result of direct viral cytolysis; the host inflammatory response, driven by the release of cytokines and chemokines from infected cells and infiltrating immune cells, likely amplifies the tissue damage and contributes to the clinical severity. This inflammatory cascade can also impair the function of the remaining, uninfected enterocytes, exacerbating the malabsorptive state.

The Role of Co-infections and Synergistic Pathology

Field studies consistently demonstrate that BToV rarely acts alone. Epidemiological surveys from diverse geographic regions, including Croatia, China, and various European countries, have documented high rates of co-infection with other enteric pathogens [2-4]. The most common co-infecting agents include BCoV, BRV, bovine viral diarrhea virus (BVDV), bovine enterovirus (BEV), and bovine norovirus (BNoV), as well as bacterial and protozoal pathogens like Cryptosporidium parvum and E. coli [2, 4]. The clinical and pathological consequences of these mixed infections are often far more severe than those caused by any single agent.

The synergistic pathology is multifactorial. For instance, BCoV, which also targets villous enterocytes, can cause even more extensive villous atrophy when present with BToV, leading to a catastrophic loss of absorptive capacity. Similarly, infection with BVDV, an immunosuppressive pestivirus, can predispose calves to more severe BToV infection by impairing both humoral and cell-mediated immune responses. The presence of C. parvum, which infects the microvillous border of enterocytes, further compromises digestive and absorptive function. This combinatorial damage overwhelms the regenerative capacity of the intestinal crypts, leading to protracted diarrhea, severe dehydration, and a significantly elevated risk of mortality. The detection of BToV in clinical samples, therefore, should always prompt investigation for concurrent pathogens, as the prognosis and therapeutic approach are heavily influenced by the full spectrum of the infectious challenge [2-4].

Comparative Pathology and Host Range Considerations

While BToV is primarily a pathogen of cattle, the torovirus genus exhibits a broad host range, with documented infections in horses (equine torovirus, EToV), pigs (porcine torovirus, PToV), and humans (human torovirus, HToV) [1]. The pathology observed in these species shares common features with bovine disease, particularly the tropism for the intestinal tract and the induction of villous atrophy. However, significant differences exist. PToV, for example, is often subclinical in swine but can cause severe diarrhea in piglets, particularly when co-infected with other pathogens like transmissible gastroenteritis virus (TGEV) or porcine epidemic diarrhea virus (PEDV) [1]. The molecular basis for these differences in virulence and host range is an active area of research, with the spike (S) protein, responsible for receptor binding and cell entry, being a key determinant. The high frequency of inter- and intra-species recombination among toroviruses, as highlighted by Ujike and Taguchi (2021), raises the concerning possibility of the emergence of novel strains with altered tissue tropism, increased virulence, or the ability to cross species barriers, underscoring the need for continued global surveillance [1]. The World Organisation for Animal Health (WOAH) recognizes the economic impact of enteric diseases in livestock, and while BToV is not currently a notifiable disease, its role in the multifactorial neonatal diarrhea complex warrants its inclusion in comprehensive diagnostic and control programs.

Diagnostic Approaches for Bovine Torovirus

The diagnostic landscape for Bovine Torovirus (BToV) has undergone a profound transformation over the past two decades, evolving from rudimentary electron microscopic identification to sophisticated molecular platforms capable of simultaneous multi-pathogen detection. This evolution is critical, as BToV, a member of the family Tobaniviridae (order Nidovirales), is increasingly recognized as a significant enteric pathogen in cattle, particularly in neonatal calves where it contributes to the complex etiology of neonatal diarrhea, a condition responsible for substantial economic losses globally [1-3]. The diagnostic challenge is compounded by the virus's frequent occurrence in mixed infections with other enteric pathogens such as Bovine Rotavirus (BRV), Bovine Coronavirus (BCoV), Bovine Viral Diarrhea Virus (BVDV), Bovine Norovirus (BNoV), and Bovine Enterovirus (BEV), necessitating diagnostic approaches that are not only sensitive and specific but also capable of disentangling complex polymicrobial interactions [2, 4]. The World Organisation for Animal Health (WOAH) recognizes the importance of robust diagnostic frameworks for emerging and re-emerging livestock pathogens, and the methodologies applied to BToV must align with international standards for test validation and quality assurance to ensure reliable surveillance and informed control strategies.

Molecular Detection: The Cornerstone of Contemporary Diagnosis

The advent of nucleic acid amplification technologies (NAATs) has revolutionized the detection of BToV, supplanting traditional methods such as virus isolation and electron microscopy, which are hampered by the fastidious nature of toroviruses in cell culture and the lack of distinctive morphological features that allow differentiation from coronaviruses [1]. Reverse transcription polymerase chain reaction (RT-PCR), and more specifically real-time quantitative RT-PCR (RT-qPCR), has become the gold standard for BToV diagnosis due to its unparalleled sensitivity, specificity, and rapid turnaround time.

Target Gene Selection and Assay Design: The design of molecular assays for BToV hinges on the selection of conserved genomic regions. The Membrane (M) gene has emerged as a preferred target for diagnostic RT-PCR and RT-qPCR assays. The M protein is a major structural component of the virion, and the encoding gene exhibits a degree of conservation sufficient for broad detection of circulating strains while providing adequate sequence variation for phylogenetic characterization. In the development of a multiplex real-time fluorescence-based quantitative PCR assay for six major calf diarrhea viruses, Meng et al. (2024) specifically targeted the BToV M gene, demonstrating its suitability as a robust diagnostic target [2]. This assay achieved a remarkably low limit of detection (LOD) for BToV at 12.8 copies/μL of plasmid DNA, with a coefficient of variation below 3% and amplification efficiency between 90-110%, underscoring the analytical rigor achievable with modern probe-based chemistries [2]. The Spike (S) gene, encoding the viral attachment protein, is another critical target, particularly for molecular epidemiological studies and genotyping. Lojkić et al. (2015) successfully employed RT-PCR targeting the BToV S gene to detect the virus in 43.2% of fecal samples from diarrheic cattle in Croatia and to perform subsequent molecular characterization, revealing nucleotide and amino acid differences compared to reference strains [3]. This dual utility, diagnostic and phylogenetic, makes the S gene an invaluable tool for both clinical detection and surveillance of viral evolution.

Multiplexing Capabilities: The clinical reality of calf diarrhea is that it is rarely a monoinfection. Epidemiological surveys consistently demonstrate high rates of co-infection with multiple viral and bacterial pathogens. Chen et al. (2024) reported that in Guangdong Province, China, the overall viral positive rate in diarrheic calves was 21.36%, with BRV (10.85%) and BEV (6.10%) being most prevalent, while BToV was detected at 0.34% [4]. This low prevalence of BToV in some regions does not diminish its clinical significance, as its pathogenic potential is often amplified in synergistic co-infections with BCoV or other agents [3]. To address this complexity, multiplex PCR platforms are indispensable. The hexaplex RT-qPCR assay developed by Meng et al. (2024) simultaneously detects BToV, BEV, BNoV, BCoV, BRV, and BVDV in a single reaction, providing a comprehensive etiological snapshot that is far more efficient and cost-effective than running six separate singleplex assays [2]. This approach not only conserves valuable sample material, often limited in neonatal calves, but also provides critical data on co-infection dynamics, which is essential for understanding pathogenesis, predicting disease severity, and guiding therapeutic and management decisions.

Metatranscriptomic Sequencing and Unbiased Detection: While targeted PCR remains the workhorse of diagnostic virology, the field is increasingly moving towards untargeted, high-throughput sequencing approaches. Metatranscriptomic sequencing (RNA-seq) offers the potential to detect any RNA virus present in a clinical sample without a priori knowledge of the pathogen, making it a powerful tool for discovering novel viruses and characterizing the entire virome. Brito et al. (2026) systematically evaluated the performance of metatranscriptomics for detecting bovine respiratory RNA viruses, including Bovine Nidovirus (BNV), a close relative of BToV, in nasal swabs [5]. Their findings are directly relevant to BToV diagnostics. They demonstrated that sequencing depth is a critical determinant of sensitivity; a depth of ≥10 million reads was sufficient to detect samples with high Ct values (up to 40) by qRT-PCR, but achieving high genome completeness required samples with Ct values <30 [5]. This implies that for BToV, which may be shed at low levels in subclinically infected animals or during the convalescent phase, metatranscriptomics may have a higher limit of detection compared to optimized qRT-PCR. Furthermore, the choice of reference genome is paramount. Brito et al. (2026) found that mapping reads to a study-assembled (consensus) genome, rather than a distantly related NCBI RefSeq genome, dramatically increased read recovery and genome coverage for BVDV-1, a virus with high genetic diversity [5]. Given the known genetic variability of BToV, particularly in the S gene [3], reliance on a single reference genome for metatranscriptomic analysis could lead to false-negative results or severely underestimated viral loads. Therefore, while metatranscriptomics holds immense promise for comprehensive pathogen discovery and surveillance, its current role in routine BToV diagnostics is complementary to, rather than a replacement for, highly sensitive and specific qRT-PCR.

Serological Approaches and the Challenge of Immune Response Interpretation

Serological diagnosis of BToV infection, primarily through enzyme-linked immunosorbent assays (ELISA), provides a window into the history of exposure and immune status of an animal or herd. However, its utility for diagnosing acute disease is limited by the kinetics of the antibody response. In neonatal calves, the presence of maternally derived antibodies (MDA) from colostrum further complicates interpretation, as seropositivity may reflect passive immunity rather than active infection. Despite these limitations, serological surveys are invaluable for determining the prevalence and geographical distribution of BToV.

ELISA Development and Standardization: The development of robust ELISAs for BToV requires high-quality antigens, typically recombinant structural proteins such as the Nucleocapsid (N) or Spike (S) proteins. The principles of test standardization are well-established in veterinary serology, as demonstrated by Bashenova et al. (2025) for BVDV diagnostics, where a domestic panel of standard sera was developed and validated against international reference materials to ensure inter-laboratory comparability [8]. Similar rigorous standards must be applied to BToV serology. The production of standardized positive and negative control sera, as well as reference antigens, is essential for ensuring that ELISA results are reproducible across different laboratories and over time. The work by Mamanova et al. (2025) on optimizing the Agar Gel Immunodiffusion (AGID) test for Bovine Leukemia Virus (BLV) highlights the critical importance of manufacturing parameters, such as agarose concentration, antigen dilution, and incubation conditions, in achieving a test system with high reproducibility and specificity that aligns with WOAH recommendations [7]. These principles of optimization and validation are directly transferable to the development and deployment of BToV ELISA kits.

Limitations and Contextual Use: The primary limitation of serology for BToV is its inability to distinguish between current active infection and past exposure. In a cross-sectional study, a high seroprevalence may simply indicate that the virus is endemic in the herd, with most animals having been exposed early in life. This is particularly problematic in calves, where MDA can persist for weeks to months. Consequently, serology is not the method of choice for diagnosing acute BToV-associated diarrhea in an individual calf. Instead, its value lies in herd-level surveillance. Longitudinal serological monitoring can reveal the dynamics of virus circulation within a herd, identify windows of susceptibility in young stock as MDA wanes, and assess the effectiveness of potential future vaccination strategies. Furthermore, paired serology (acute and convalescent sera) can retrospectively confirm infection by demonstrating a four-fold or greater rise in antibody titer, but this is impractical for clinical decision-making. Therefore, while serology provides essential epidemiological context, it must be interpreted with caution and is best used in conjunction with direct pathogen detection methods like RT-qPCR.

Differential Diagnosis and the Role of Advanced Imaging and Ancillary Testing

The clinical presentation of BToV infection, watery diarrhea, dehydration, and lethargy in young calves, is indistinguishable from that caused by a host of other enteric pathogens, including BCoV, BRV, BVDV, Cryptosporidium parvum, and enterotoxigenic Escherichia coli (ETEC) [2, 4]. Therefore, a definitive diagnosis of BToV cannot be made on clinical grounds alone; it is entirely dependent on laboratory confirmation. The differential diagnostic process is thus a critical component of the diagnostic approach.

Systematic Exclusion of Common Pathogens: A comprehensive diagnostic workup for a diarrheic calf should include testing for the most common viral and parasitic agents. The multiplex qPCR assays described previously are ideally suited for this purpose, as they can simultaneously rule in or rule out multiple viral causes [2]. For bacterial and parasitic causes, traditional methods such as fecal culture, Gram staining, and microscopy remain relevant. The Gram stain of fecal smears can rapidly identify the presence of Clostridium perfringens or large numbers of Gram-negative rods suggestive of ETEC. Similarly, acid-fast staining is used to detect Cryptosporidium oocysts. The work by Suzuki and Isobe (2025) on Gram staining of milk precipitates (MGS) for mastitis diagnosis demonstrates that even simple, rapid staining techniques, when properly validated, can provide valuable point-of-care information with reasonable sensitivity and specificity (0.62 and 0.90, respectively, for all pathogens) [10]. While applied to milk, the principle of using a rapid, low-cost staining method to guide initial clinical decisions before culture results are available is highly relevant to enteric disease diagnostics.

The Role of Clinical Pathology and Imaging: While not specific for BToV, ancillary diagnostic tests are crucial for assessing the severity of disease and guiding supportive care. Hematology and serum biochemistry can reveal the degree of dehydration (elevated packed cell volume, total protein), electrolyte imbalances (hyponatremia, hyperkalemia), and metabolic acidosis (decreased bicarbonate, increased anion gap) that accompany severe diarrhea. The establishment of period-specific hematology reference intervals for dairy cows, as done by Tsiamadis et al. (2022), is critical for accurately interpreting these results, as marked physiological changes occur in the periparturient and neonatal periods [9]. In chronic or severe cases, advanced imaging such as ultrasonography can be used to assess intestinal wall thickness, motility, and the presence of fluid-filled loops, providing supportive evidence of enteritis. Computed tomography (CT), while not a routine field diagnostic tool, has been used to provide detailed anatomical reference for the bovine head and respiratory tract [11], and similar principles could be applied to research settings investigating the pathophysiology of BToV infection. Ultimately, the diagnosis of BToV rests on the molecular detection of its nucleic acid, but the integration of clinical pathology and differential diagnostic testing provides a holistic picture of the disease process, enabling the clinician to manage the patient effectively while awaiting definitive laboratory results.

Prevention and Control Strategies for Bovine Torovirus Infection

The Challenge of a Neglected Enteric Pathogen

Bovine torovirus (BToV) occupies a uniquely challenging position in the realm of veterinary infectious disease control. Unlike its well-characterized nidovirus relatives, such as bovine coronavirus (BCoV), BToV has historically been overlooked, a consequence of diagnostic limitations and the often subclinical nature of its infections [1]. However, a growing body of evidence compels a reassessment. BToV has been detected worldwide in diarrheic calves, contributing to substantial economic losses in the cattle industry [1]. The virus is frequently identified in mixed enteric infections, acting synergistically with other pathogens such as BCoV, bovine rotavirus (BRV), and bovine viral diarrhea virus (BVDV) to exacerbate disease severity [3, 4]. This polymicrobial context is the central dilemma for prevention and control: strategies cannot target BToV in isolation but must be embedded within a comprehensive, multi-pathogen health management framework. The fundamental lack of licensed vaccines or specific antiviral therapies for BToV [2, 4] further dictates that control must rely on a robust, multi-layered foundation of biosecurity, rigorous surveillance, and optimized herd management.

Foundational Biosecurity and Management Practices

Given the fecal-oral transmission route of BToV, the cornerstone of any control program is the strict implementation of on-farm biosecurity. This begins with meticulous sanitation. Calf housing, feeding equipment, and water sources must be subjected to rigorous cleaning and disinfection protocols, as the virus can persist in the environment and serve as a continuous source of infection for naive animals. The adoption of an all-in-all-out management system for calf pens, coupled with a sufficient downtime between groups, is critical to break the cycle of transmission. Furthermore, the introduction of new animals into a herd represents a significant risk. As demonstrated in control programs for other bovine pathogens, the quarantine of purchased animals and the screening of their health status are paramount [14, 15]. This is particularly relevant for BToV, where adult cattle can be subclinically infected and shed the virus, acting as reservoirs for susceptible calves [1]. The World Organisation for Animal Health (WOAH) principles for compartmentalization and the implementation of pathogen-specific biosecurity plans should be adapted to address the risk of enteric nidoviruses. Although BToV is not currently a notifiable disease, the infrastructure for controlling economically significant pathogens like BVDV, as exemplified by the Irish eradication program, with its movement restrictions, central databases, and private veterinary practitioner involvement, provides a template for the level of coordinated action that could be adapted for BToV control in high-prevalence settings [15].

Surveillance, Early Detection, and Diagnostic Infrastructure

Effective control is predicated on accurate and timely diagnosis. The historical under-detection of BToV is a primary obstacle. Traditional diagnostic methods are often inadequate for distinguishing BToV from the more commonly suspected BCoV or BRV, especially in mixed infections [3]. The development and deployment of advanced molecular tools are therefore non-negotiable. The multiplex real-time quantitative PCR (qPCR) assay developed by Meng et al. [2] represents a paradigm shift, enabling the simultaneous detection of BToV alongside five other major calf diarrhea viruses (BEV, BNoV, BCoV, BRV, BVDV) with high sensitivity and specificity. This approach is not merely a convenience; it is an epidemiological necessity. Without such a tool, BToV infections are systematically missed, and the true prevalence and clinical impact of the virus remain hidden, preventing evidence-based decisions on control measures. The study by Lojkić et al. [3] in Croatia, which found BToV in 43.2% of diarrheic samples, underscores how reliance on single-pathogen testing can lead to a gross underestimation of the role of BToV in enteric disease complexes.

To move beyond prevalence studies and into active control, surveillance must be integrated into a real-time, actionable framework. The targeted next-generation sequencing (tNGS) approach, as evaluated for bovine pathogens by Anis et al. [19], offers a powerful alternative to qPCR, detecting a wide array of agents from a single sample, including pathogens that might not have been specifically tested for. The utility of metatranscriptomic sequencing has also been demonstrated for bovine nidoviruses, though its sensitivity, particularly for samples with high Ct values, requires careful optimization of sequencing depth and reference genome selection [5]. A strategic surveillance system, modeled on syndromic monitoring of laboratory test data, could be established to track the incidence of BToV and other enteric pathogens [22]. This would involve standardizing the diagnostic algorithms used by veterinary diagnostic laboratories, ensuring that BToV is routinely included in the panel for calf diarrhea cases. The work by Chikh et al. [17] on the OASIS evaluation of French diagnostic surveillance for cattle diseases highlights that technical expertise alone is insufficient; the system requires formalized reporting guidelines, feedback mechanisms, and clear case definitions to function effectively. A key area for future research is the development of rapid, pen-side diagnostic tests for BToV, which could empower producers and veterinarians to make immediate management decisions, such as isolating affected calves, before laboratory results are available, a need highlighted by the development of such tests for other bovine infections [18, 24].

The Path to Vaccination and Immunoprophylaxis

The single greatest gap in the BToV control armamentarium is the absence of an effective vaccine. The molecular biology of toroviruses, particularly the function of the spike (S) protein in host cell entry and the membrane (M) protein, has been partially elucidated, providing potential targets for vaccine development [1, 2]. However, the path to a commercial vaccine is fraught with challenges. The genetic and antigenic diversity of circulating BToV strains, as evidenced by phylogenetic analyses that classify strains into distinct genotypes (e.g., Type I and Type II) [4], suggests that a monovalent vaccine might offer incomplete protection. Furthermore, the frequent recombination events observed among toroviruses could lead to the rapid emergence of vaccine-escape variants [1]. In the interim, non-specific immunoprophylaxis strategies warrant investigation. The use of immunomodulatory substances to bolster innate immunity in young calves, particularly during the critical first weeks of life when they are most susceptible, could reduce disease severity. The exploration of plant-derived compounds with known antiviral and immunostimulatory properties, such as those found in propolis or various polyphenolic-rich extracts, is an emerging field that holds promise as a supportive strategy for enteric infections [13, 25, 26]. A strategic priority for the veterinary research community should be the development of a multivalent, recombinant vaccine targeting the S protein of the most prevalent BToV genotypes, potentially combined with antigens from BCoV and BRV to provide comprehensive protection against the major viral causes of calf diarrhea. This would require a concerted, industry-wide effort, mirroring the collaborative initiatives that have driven progress against other recalcitrant bovine pathogens.

Integrated Control and the One Health Imperative

Ultimately, the prevention and control of BToV cannot be divorced from the broader context of herd health and antimicrobial stewardship. Diarrheal disease in calves is a leading indication for the use of antimicrobials, yet in cases of viral etiology, such treatment is ineffective and contributes to the global crisis of antimicrobial resistance (AMR) [12, 16, 20]. Accurate diagnosis of BToV is therefore a direct intervention against AMR. When BToV is identified as the primary or co-infecting agent, the use of antibiotics for the uncomplicated diarrhea should be discouraged, and therapy should focus on supportive care, including fluid and electrolyte replacement. Furthermore, the control of BToV must be integrated with programs targeting other immunosuppressive and enteric pathogens, particularly BVDV. Persistently infected (PI) animals with BVDV can profoundly suppress immune function in a herd, making them more susceptible to secondary infections like BToV [8, 15]. Therefore, eradicating BVDV from a herd is a prerequisite for effective BToV control. The implementation of best management practices, such as ensuring adequate colostrum intake (passive transfer of immunity) and minimizing stress through optimized nutrition and housing, are non-specific but highly effective measures that reduce the overall disease pressure on young calves. A holistic, data-driven approach, facilitated by digital herd management tools and a functional network of veterinarians, diagnostic laboratories, and producers, is the only sustainable path forward for managing this elusive but economically important virus [21, 23].

References

[1] Ujike M, Taguchi F. Recent Progress in Torovirus Molecular Biology. Viruses. 2021. DOI: https://doi.org/10.3390/v13030435

[2] Meng W, Chen Z, Jiang Q, Chen J, Guo X, Ma Z, et al.. A multiplex real-time fluorescence-based quantitative PCR assay for calf diarrhea viruses. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2023.1327291

[3] Lojkić I, Krešić N, Šimić I, Bedeković T. Detection and molecular characterisation of bovine corona and toroviruses from Croatian cattle. BMC Veterinary Research. 2015. DOI: https://doi.org/10.1186/s12917-015-0511-9

[4] Chen J, Meng W, Zeng H, Wang J, Liu S, Jiang Q, et al.. Epidemiological survey of calf diarrhea related viruses in several areas of Guangdong Province. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1441419

[5] Brito B, Frost M, Webster J, To J, Kirkland PD. Quantifying the impact of sequencing depth and reference genome choice on metatranscriptomic detection of four bovine RNA viruses.. Research in Veterinary Science. 2026. DOI: https://doi.org/10.1016/j.rvsc.2026.106125

[6] Tong C, Liu Q, Zhang Z, Liang Y, Feng W, Yu H, et al.. Identification of a target polypeptide of the CD169 receptor of bovine macrophage using a phage display peptide library.. Developmental and Comparative Immunology. 2025. DOI: https://doi.org/10.1016/j.dci.2025.105359

[7] Mamanova S, Bashenova E, Kaimoldina S, Nissanova R, Akshalova P, Kirpichenko V, et al.. OPTIMIZATION OF THE MANUFACTURING CONDITIONS OF AN AGID TEST SYSTEM FOR THE DIAGNOSIS OF BOVINE LEUKEMIA. Eurasian journal of applied biotechnology. 2025. DOI: https://doi.org/10.11134/btp.3.2025.11

[8] Bashenova E, Kirpichenko V, Nissanova R, Mamanova S, Dyusenov SM, Lesov B, et al.. DIAGNOSIS OF BOVINE VIRAL DIARRHEA: THE IMPORTANCE OF STANDARDIZING CONTROL SERA FOR INTERLABORATORY COMPARISONS. Ġylym ža̋ne bìlìm. 2025. DOI: https://doi.org/10.52578/2305-9397-2025-3-1-237-248

[9] Tsiamadis V, Kougioumtzis A, Siachos N, Panousis N, Kritsepi-Konstantinou M, Valergakis G. Hematology reference intervals during the prepartum period, first week after calving, and peak lactation in clinically healthy Holstein cows.. Veterinary clinical pathology. 2022. DOI: https://doi.org/10.1111/vcp.13069

[10] Suzuki N, Isobe N. Determining causal pathogens and inflammatory state of mastitis in dairy cows via Gram staining of precipitates in milk. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2024.1492564

[11] Montel C, Isler F, Cartiaux B, Maillard R, Mogicato G. Computed Tomography of the Nasal Cavities and Paranasal Sinuses of Cattle at Different Ages. Veterinary Medicine and Science. 2026. DOI: https://doi.org/10.1002/vms3.70893

[12] Langhorne C, Gupta S, Horsman S, Wood C, Wood B, Barker L, et al.. Bacterial culture and antimicrobial susceptibility results from bovine milk samples submitted to four veterinary diagnostic laboratories in Australia from 2015 to 2019. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1232048

[13] Pereira MdPM, Januario GB, Fonseca LMd, Assis DCSd, Brito JCM. Propolis as a therapeutic alternative in mastitis treatment: A systematic review of veterinary clinical trials.. Research in Veterinary Science. 2025. DOI: https://doi.org/10.1016/j.rvsc.2025.105946

[14] Shome R, Natesan K, Kalleshamurthy T, Yadav C, Sahay S, Skariah S, et al.. Management of bovine brucellosis in organized dairy herds through the identification of risk factors: A cross-sectional study from Karnataka, India. Veterinary World. 2023. DOI: https://doi.org/10.14202/vetworld.2023.1122-1130

[15] Graham D, More S, O'Sullivan P, Lane E, Barrett D, Lozano J, et al.. The Irish Programme to Eradicate Bovine Viral Diarrhoea Virus, Organization, Challenges, and Progress. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.674557

[16] Astrup L, Pedersen K, Farre M. Microbiological Diagnoses on Clinical Mastitis, Comparison between Diagnoses Made in Veterinary Clinics versus in Laboratory Applying MALDI-TOF MS. Antibiotics. 2022. DOI: https://doi.org/10.3390/antibiotics11020271

[17] Chikh M, Ngwa-Mbot D, Morignat E, Mémeteau S, Amat J. OASIS evaluation of the French laboratory diagnostic surveillance system: right people, right techniques but imperfect use. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1419034

[18] Pumipuntu N, Kulpeanprasit S, Santajit S, Tunyong W, Kong-ngoen T, Hinthong W, et al.. Screening method for Staphylococcus aureus identification in subclinical bovine mastitis from dairy farms. Veterinary World. 2017. DOI: https://doi.org/10.14202/vetworld.2017.721-726

[19] Anis E, Hawkins I, Ilha M, Woldemeskel M, Saliki J, Wilkes R. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples. Journal of Clinical Microbiology. 2018. DOI: https://doi.org/10.1128/JCM.00399-18

[20] Romanò A, Ivanović I, Segessemann T, Rojo LV, Widmer J, Egger L, et al.. Elucidation of the Bovine Intramammary Bacteriome and Resistome from healthy cows of Swiss dairy farms in the Canton Tessin. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1183018

[21] Pobedinskiy V, Pobedinskiy A, Iovlev GA. Development of an Intelligent System for Diagnosing Rumen Acidosis in Cows. Part 1: Formalization of Tasks. Russian Journal of Veterinary Pathology. 2026. DOI: https://doi.org/10.23947/2949-4826-2025-24-4-17-26

[22] Burkom H, Estberg L, Akkina J, Meidenbauer KL, Hennessey M. Selection of Syndromes and Algorithms for Monitoring Bovine Laboratory Test Data. Online Journal of Public Health Informatics. 2018. DOI: https://doi.org/10.5210/ojphi.v10i1.8340

[23] Mlala S, Dedieu F, Hénaux V. Organisation of local actors and data reporting in veterinary public health. Online Journal of Public Health Informatics. 2019. DOI: https://doi.org/10.5210/ojphi.v11i1.9884

[24] Bronsvoort B, Koterwas B, Land F, Handel I, Tucker J, Morgan K, et al.. Comparison of a Flow Assay for Brucellosis Antibodies with the Reference cELISA Test in West African Bos indicus. PLoS ONE. 2009. DOI: https://doi.org/10.1371/journal.pone.0005221

[25] (Šukele) RT. Antibacterial activity against bovine mastitis-inducing pathogens and antiradical activity of polyphenolic-compounds-containing plant extracts. Summary of the Doctoral Thesis. . None. DOI: https://doi.org/10.25143/prom-rsu_2025-04_dts

[26] (Šukele) RT. Antibacterial activity against bovine mastitis-inducing pathogens and antiradical activity of polyphenolic-compounds-containing plant extracts. Doctoral Thesis. . None. DOI: https://doi.org/10.25143/prom-rsu_2025-04_dt